Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Tuberculosis

  Free Subscription


14.01.2019

2 Antimicrob Agents Chemother
1 Eur Respir J
17 Int J Tuberc Lung Dis
1 J Bacteriol
1 Lancet
2 Lancet Respir Med
2 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. WASSERMAN S, Denti P, Brust JCM, Tareq M, et al
    Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02164.
    PubMed     Text format     Abstract available

  2. ZIMENKOV D
    Mutation in luxR Family Transcriptional Regulator Rv0890c Is Not a Marker of Linezolid Resistance.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    Eur Respir J

  3. VAN LETH F, Brinkmann F, Cirillo DM, Dheda K, et al
    The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    Int J Tuberc Lung Dis

  4. NKURUNZIZA J, Karstaedt AS, Louw R, Padanilam X, et al
    Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2018;22:1469-1474.
    PubMed     Text format     Abstract available

  5. ZAWEDDE-MUYANJA S, Manabe YC, Sewankambo NK, Nakiyingi L, et al
    Xpert((R)) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1475-1480.
    PubMed     Text format     Abstract available

  6. GE E, Li D, Luo M, Tsui KWS, et al
    Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status.
    Int J Tuberc Lung Dis. 2018;22:1462-1468.
    PubMed     Text format     Abstract available

  7. OPOLLO VS, Wu X, Hughes MD, Swindells S, et al
    HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.
    Int J Tuberc Lung Dis. 2018;22:1443-1449.
    PubMed     Text format     Abstract available

  8. HAMADA Y, Ford N, Schenkel K, Getahun H, et al
    Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:1422-1428.
    PubMed     Text format     Abstract available

  9. VAN CREVEL R, Koesoemadinata R, Hill PC, Harries AD, et al
    Clinical management of combined tuberculosis and diabetes.
    Int J Tuberc Lung Dis. 2018;22:1404-1410.
    PubMed     Text format     Abstract available

  10. MENZIES NA, Hill AN, Cohen T, Salomon JA, et al
    The impact of migration on tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2018;22:1392-1403.
    PubMed     Text format     Abstract available

  11. AUER C, Bosch-Capblanch X
    Taking tuberculosis seriously requires that we take poverty seriously: reinstating the ethics of public health.
    Int J Tuberc Lung Dis. 2018;22:1390-1391.
    PubMed     Text format    

  12. PHO Y, Nhem S, Sok C, By B, et al
    Melioidosis in patients with suspected tuberculosis in Cambodia: a single-center cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:1481-1485.
    PubMed     Text format     Abstract available

  13. CHUA AP, Lim LK, Gan SH, Chee CB, et al
    The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Int J Tuberc Lung Dis. 2018;22:1486-1494.
    PubMed     Text format     Abstract available

  14. MOK J, Kang BH, Kim HJ, Lee SJ, et al
    Drug resistance in extra-pulmonary tuberculosis in South Korea: comparison with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0109.
    PubMed     Text format     Abstract available

  15. LE H, Nguyen N, Tran P, Hoa N, et al
    Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0268.
    PubMed     Text format     Abstract available

  16. YE R, Wang C, Zhao L, Wu X, et al
    Characteristics of miliary tuberculosis in pregnant women after in vitro fertilisation and embryo transfer.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0223.
    PubMed     Text format     Abstract available

  17. BHARGAVA M, Bhargava A, Akshaya KM, Shastri SG, et al
    Nutritional assessment and counselling of tuberculosis patients at primary care in India: do we measure up?
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0333.
    PubMed     Text format     Abstract available

  18. YU S, Shen J, Lao S, Yang B, et al
    Distinct functions of CXCR3(+) and CCR4(+)CD4(+) T-cells accumulated in human tuberculosis pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:1514-1522.
    PubMed     Text format     Abstract available

  19. ASLAM MV, Owusu-Edusei K, Marks SM, Asay GRB, et al
    Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States.
    Int J Tuberc Lung Dis. 2018;22:1495-1504.
    PubMed     Text format     Abstract available

  20. CHAKAYA J, Castro JL, Jensen PM, Fujiwara PI, et al
    A new era for global tuberculosis: holding leaders accountable for promises.
    Int J Tuberc Lung Dis. 2018;22:1387.
    PubMed     Text format    


    J Bacteriol

  21. JOSHI AC, Kaur P, Nair RK, Lele DS, et al
    Selectivity among anti-sigma factors by Mycobacterium tuberculosis ClpX influences intracellular levels of Extracytoplasmic Function sigma factors.
    J Bacteriol. 2019 Jan 7. pii: JB.00748-18. doi: 10.1128/JB.00748.
    PubMed     Text format     Abstract available


    Lancet

  22. FERRY G
    Dorothy Stopford Price and the control of tuberculosis in Ireland.
    Lancet. 2019;393:20.
    PubMed     Text format    


    Lancet Respir Med

  23. NDJEKA N
    Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis - Authors' reply.
    Lancet Respir Med. 2018;6:e57.
    PubMed     Text format    

  24. YATES TA
    Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis.
    Lancet Respir Med. 2018;6:e56.
    PubMed     Text format    


    N Engl J Med

  25. ALSULTAN A, Ashkin D, Peloquin CA
    Bacterial Factors and Relapse after Tuberculosis Therapy.
    N Engl J Med. 2019;380:197.
    PubMed     Text format    


  26. Bacterial Factors and Relapse after Tuberculosis Therapy.
    N Engl J Med. 2019;380:197-198.
    PubMed     Text format    


    PLoS One

  27. ZEGEYE A, Dessie G, Wagnew F, Gebrie A, et al
    Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210422.
    PubMed     Text format     Abstract available

  28. OHENE SA, Bakker MI, Ojo J, Toonstra A, et al
    Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana.
    PLoS One. 2019;14:e0209650.
    PubMed     Text format     Abstract available

  29. THAKORE N, Norville R, Franke M, Calderon R, et al
    Automated TruTip nucleic acid extraction and purification from raw sputum.
    PLoS One. 2018;13:e0199869.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: